Bio-Techne and its subsidiaries develop, manufacture and sell biotechnology life science reagents, instruments and services for the research and clinical diagnostic markets.Co.'s segments: Protein Sciences, which developes and manufactures purified proteins and reagent solutions, cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies; and Diagnostics and Genomics, which develops and manufactures diagnostic products, including Food and Drug Administration-regulated controls, calibrators, blood gas and clinical chemistry controls and other reagents for Original Equipment Manufacturer.
NIC is a provider of digital government services that help governments use technology. The company operates through two channels: state enterprise businesses and its software and services businesses. In its state enterprise businesses, the company has contracts with state and local governments to designs, builds, and operates digital government services on an enterprise-wide basis on their behalf. In its software and services businesses, the company provides certain payment processing services, software development and digital government services, other than those provided on an enterprise-wide basis, to federal agencies, as well as state and local governments.
Ultimate Software Group is a provider of cloud-based human capital management solutions, often referred to as human capital management (HCM). The company's UltiPro product suite (UltiPro) is a solution that has human resources, payroll, and benefits management and includes global people management. The solution is delivered via software-as-a-service to organizations based in the U.S. and Canada, including those with global workforces. UltiPro is designed to manage the employee life cycle from recruitment to retirement. The company's cloud offering of UltiPro provides Web-based access to HCM functionality for organizations that want to simplify delivery and support of their business applications.
In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:
We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.
The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.